Anti-Cancer Agents in Medicinal Chemistry

(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Editor-in-Chief

Simone Carradori
Department of Pharmacy
“G. d’Annunzio” University of Chieti-Pescara
Chieti
(Italy)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 12 Issue: 2, February

Editorial [ Hot Topic:Emerging Anticancer Effects of Antiresorptive Therapies (Guest Editor: Vera Hirsh)]

Volume:12   Issue: 2
Pp: 94-94
Vera Hirsh
DOI: 10.2174/187152012799014940
Published on: 01 March, 2012

The Chemistry of Bisphosphonates: From Antiscaling Agents to Clinical Therapeutics

Volume:12   Issue: 2
Pp: 95-101
Leo Widler, Wolfgang Jahnke and Jonathan R. Green
DOI: 10.2174/187152012799014959
Published on: 01 March, 2012

Potential Anticancer Properties of Bisphosphonates: Insights From Preclinical Studies

Volume:12   Issue: 2
Pp: 102-113
Philippe Clezardin
DOI: 10.2174/187152012799014977
Published on: 01 March, 2012

Anticancer Activity of Bisphosphonates in Breast Cancer

Volume:12   Issue: 2
Pp: 114-122
Michael Gnant
DOI: 10.2174/187152012799014931
Published on: 01 March, 2012

Bisphosphonate Anticancer Activity in Multiple Myeloma

Volume:12   Issue: 2
Pp: 123-128
Evangelos Terpos
DOI: 10.2174/187152012799014986
Published on: 01 March, 2012

Bisphosphonate Anticancer Activity in Prostate Cancer and Other Genitourinary Cancers

Volume:12   Issue: 2
Pp: 129-136
Fred Saad and Peter Mulders
DOI: 10.2174/187152012799014995
Published on: 01 March, 2012

Bisphosphonates and Breast Cancer Prevention

Volume:12   Issue: 2
Pp: 144-150
Rowan T. Chlebowski and Nananda Col
DOI: 10.2174/187152012799014913
Published on: 01 March, 2012

Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance

Volume:12   Issue: 2
Pp: 151-162
Sylvia S. Gayle, Samuel L.M. Arnold, Ruth M. O'Regan and Rita Nahta
DOI: 10.2174/187152012799015002
Published on: 01 March, 2012

Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers? open access plus

Volume:12   Issue: 2
Pp: 163-171
Tomoya Yokota
DOI: 10.2174/187152012799014968
Published on: 01 March, 2012

Procathepsin D as a Tumor Marker, Anti-Cancer Drug or Screening Agent

Volume:12   Issue: 2
Pp: 172-175
Vaclav Vetvicka and Martin Fusek
DOI: 10.2174/187152012799014904
Published on: 01 March, 2012